3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Colorectal Neoplasms
7
Pancreatic Neoplasms
4
Rectal Neoplasms
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Resectable MMR-deficient Solid Tumors
1
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
1
Prostatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Microsatellite Stable Rectal Carcinoma
1
Lymphoma
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Adenocarcinoma
1
Interventions
balstilimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Resectable MMR-deficient Solid Tumors
×
balstilimab
×
Clear all
NCT06279130
2026-03-05
NEOASIS
The Netherlands Cancer Institute
Phase 2/3
Recruiting
133 enrolled